Compositions and methods for inhibiting Wnt-dependent solid tumor cell growth
    8.
    发明授权
    Compositions and methods for inhibiting Wnt-dependent solid tumor cell growth 有权
    用于抑制Wnt依赖性实体瘤细胞生长的组合物和方法

    公开(公告)号:US07723477B2

    公开(公告)日:2010-05-25

    申请号:US11589931

    申请日:2006-10-31

    摘要: The present invention relates to compositions and methods for characterizing, diagnosing, and treating cancer. In particular the invention provides the means and methods for the diagnosis, characterization, prognosis and treatment of cancer and specifically targeting cancer stem cells. The present invention provides a soluble FZD receptor comprising an extracellular domain of a human FZD receptor that inhibits growth of tumor cells. The present invention still further provides a soluble receptor comprising a Fri domain of a human FZD receptor that binds a ligand of a human FZD receptor and said soluble receptor is capable of inhibiting tumor growth. The present invention still further provides a method of treating cancer comprising administering a soluble FZD receptor comprising for example, either an extracellular domain of a human FZD receptor or a Fri domain of a human FZD receptor, in an amount effective to inhibit tumor growth.

    摘要翻译: 本发明涉及用于表征,诊断和治疗癌症的组合物和方法。 特别地,本发明提供了用于癌症的诊断,表征,预后和治疗以及特异性靶向癌症干细胞的方法和方法。 本发明提供了包含抑制肿瘤细胞生长的人FZD受体的细胞外结构域的可溶性FZD受体。 本发明还提供一种可溶性受体,其包含结合人FZD受体的配体的人FZD受体的Fri结构域,并且所述可溶性受体能够抑制肿瘤生长。 本发明还提供一种治疗癌症的方法,其包括以有效抑制肿瘤生长的量给予包含例如人FZD受体的细胞外结构域或人FZD受体的Fri结构域的可溶性FZD受体。